Cargando…

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

Oxygenated hemoglobin (OxyHem) in arterial blood may reflect disease severity in patients with systemic sclerosis (SSc). The aim of this study was to analyze the predictive value of OxyHem in SSc patients screened for pulmonary hypertension (PH). OxyHem (g/dl) was measured by multiplying the concent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xanthouli, Panagiota, Gordjani, Ojan, Benjamin, Nicola, Trudzinski, Franziska C., Egenlauf, Benjamin, Harutyunova, Satenik, Marra, Alberto M., Milde, Nicklas, Nagel, Christian, Blank, Norbert, Lorenz, Hanns-Martin, Grünig, Ekkehard, Eichstaedt, Christina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892512/ https://www.ncbi.nlm.nih.gov/pubmed/36725894 http://dx.doi.org/10.1038/s41598-023-28608-x

Ejemplares similares

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
por: Xanthouli, Panagiota, et al.
Publicado: (2022)

Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension
por: Xanthouli, Panagiota, et al.
Publicado: (2023)

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up
por: Xanthouli, Panagiota, et al.
Publicado: (2020)

Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study
por: Fischer, Lukas, et al.
Publicado: (2018)

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
por: Pan, Zixuan, et al.
Publicado: (2019)

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri(®)): a prospective, 6-months, open label, observational, non-interventional study
por: Degering, Julia, et al.
Publicado: (2023)

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study
por: Eichstaedt, Christina A., et al.
Publicado: (2020)

EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension
por: Eichstaedt, Christina A., et al.
Publicado: (2016)

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?
por: Theobald, Vivienne, et al.
Publicado: (2023)

Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
por: Nagel, Christian, et al.
Publicado: (2015)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
por: Xanthouli, Panagiota, et al.
Publicado: (2021)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
por: Marra, Alberto M., et al.
Publicado: (2018)

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
por: Theobald, Vivienne, et al.
Publicado: (2022)

The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review
por: Palevičiūtė, Eglė, et al.
Publicado: (2022)

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
por: Eichstaedt, Christina A., et al.
Publicado: (2022)

Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis
por: Grünig, Ekkehard, et al.
Publicado: (2020)

Identification of a New Intronic BMPR2-Mutation and Early Diagnosis of Heritable Pulmonary Arterial Hypertension in a Large Family with Mean Clinical Follow-Up of 12 Years
por: Hinderhofer, Katrin, et al.
Publicado: (2014)

Improved Survival for Patients with Systemic Sclerosis–associated Pulmonary Arterial Hypertension: For Real?
por: Xanthouli, Panagiota
Publicado: (2022)

BMPR2 Promoter Variants Effect Gene Expression in Pulmonary Arterial Hypertension Patients
por: Song, Jie, et al.
Publicado: (2020)

Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease
por: Melzig, Claudius, et al.
Publicado: (2022)

Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients
por: Lerche, Marianne, et al.
Publicado: (2019)

Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres
por: Wissmüller, Max, et al.
Publicado: (2022)

Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial
por: Palevičiūtė, Eglė, et al.
Publicado: (2023)

Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention
por: Grunig, Gabriele, et al.
Publicado: (2018)

Mutation in BMPR2 Promoter: A ‘Second Hit’ for Manifestation of Pulmonary Arterial Hypertension?
por: Viales, Rebecca Rodríguez, et al.
Publicado: (2015)

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
por: Köhler, Birgit Maria, et al.
Publicado: (2018)

Anhaltende Belastungsdyspnoe nach Corona-Erkrankung
por: Trudzinski, Franziska
Publicado: (2023)

Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
por: Kvacskay, Peter, et al.
Publicado: (2022)

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Führt Zwerchfellschwäche zu Long Covid?
por: C. Trudzinski, Franziska
Publicado: (2023)

Imaging the heart in pulmonary hypertension: an update
por: Grünig, Ekkehard, et al.
Publicado: (2015)

Role of total lung stress on the progression of early COVID-19 pneumonia: collinearity and potential confounders
por: Neetz, Benjamin, et al.
Publicado: (2021)

Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis
por: Torres, Lidiane de Souza, et al.
Publicado: (2015)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
por: Grünig, Ekkehard, et al.
Publicado: (2012)

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial
por: Ehlken, Nicola, et al.
Publicado: (2016)

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH
por: Eichstaedt, Christina A., et al.
Publicado: (2023)

Defective Suppressor Function of Human CD4(+) CD25(+) Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II
por: Kriegel, Martin A., et al.
Publicado: (2004)

Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells
por: Merkt, Wolfgang, et al.
Publicado: (2016)

Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
por: Pfarr, Nicole, et al.
Publicado: (2013)

Chromosomal evidence of species status and evolutionary relationships of the black fly Prosimulium petrosum (Diptera, Simuliidae) in Armenia
por: Vlasov, Sergey, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4n2egdl3bjhaejjovrmooidncl